<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TIA1L Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>TIA1L (TIA-1 Like Protein)</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>TIA-1-like, TIAL1</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[TIA1L](/genes/tia1l)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q8WY31</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~42 kDa (386 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, stress granules</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>TIA family, RNA-binding proteins</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Brain, testis, multiple tissues</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TIA1L Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>TIA1L (TIA-1 Like Protein)</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>TIA-1-like, TIAL1</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[TIA1L](/genes/tia1l)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q8WY31</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~42 kDa (386 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, stress granules</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>TIA family, RNA-binding proteins</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Brain, testis, multiple tissues</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
TIA1L (TIA-1 Like Protein, also known as TIA-1-like) is an RNA-binding protein that plays critical roles in post-transcriptional gene regulation, stress granule formation, and mRNA translation control. As a member of the TIA family of RNA-binding proteins, TIA1L shares structural and functional similarity with TIA1 (TIA-1 cytotoxic granule-associated RNA binding protein), a well-characterized regulator of apoptosis and stress responses. This page provides comprehensive information about TIA1L's structure, molecular functions, and implications in neurodegenerative diseases.
```{.infobox .infobox-protein}
```
TIA1L contains several functional domains that mediate its RNA binding and protein-protein interactions:
RNA Recognition Motif (RRM) Domains
TIA1L contains three RNA recognition motifs (RRM1-RRM3), each consisting of a four-stranded antiparallel β-sheet flanked by two α-helices. These domains bind to specific RNA sequences, particularly uridine-rich sequences and adenine-rich regulatory elements in mRNA 3' untranslated regions (UTRs).
N-terminal Domain
The N-terminal region contains nuclear localization signals (NLS) and nuclear export signals (NES), allowing TIA1L to shuttle between the nucleus and cytoplasm. This nucleocytoplasmic shuttling is important for its functions in both transcription and translation regulation.
TIA1L performs several critical biochemical functions:
Stress Granule Assembly
TIA1L is a core component of stress granules (SGs), cytoplasmic mRNA-protein aggregates that form in response to various cellular stresses including oxidative stress, heat shock, and viral infection. Stress granules contain stalled translation preinitiation complexes and function to preserve mRNA during stress[@anderson2018].
mRNA Translation Repression
Through interaction with the translation initiation machinery, TIA1L represses the translation of specific mRNAs. This repression is often selective, targeting mRNAs encoding proteins involved in growth, proliferation, and other functions that are less essential during stress.
mRNA Stability Regulation
TIA1L binds to specific mRNAs and influences their stability. Binding to 3' UTR AU-rich elements (AREs) can either stabilize or destabilize mRNA transcripts, depending on the context.
Alternative Splicing Regulation
Although primarily cytoplasmic, TIA1L may influence alternative splicing through interaction with splicing factors in the nucleus. This function is more characteristic of TIA1 than TIA1L.
TIA1L is expressed in the nervous system:
TIA1L has been implicated in ALS pathogenesis:
Stress Granule Dysregulation: ALS is associated with aberrant stress granule dynamics. TIA1L-positive stress granules persist in ALS models and patient tissue[@li2019].
Mutual Aggregation: TIA1L colocalizes with TDP-43 in ALS inclusions, suggesting that stress granule dysfunction contributes to TDP-43 pathology.
Therapeutic Potential: Modulating stress granule dynamics or enhancing TIA1L function may provide neuroprotective benefits.
FTD with TDP-43 Pathology: FTD-TDP is characterized by TDP-43 inclusions. TIA1L is often sequestered in these inclusions, losing its normal function[@markov2018].
Stress Granule Pathology: FTD is associated with stress granule abnormalities similar to ALS.
Alternative Splicing: TIA1L dysfunction may contribute to the alternative splicing changes observed in FTD.
StressResponse: Alzheimer's disease is associated with chronic oxidative stress, leading to persistent stress granule formation.
Translation Dysregulation: TIA1L-mediated translation repression may contribute to the translation deficits observed in Alzheimer's disease.
Protein Quality Control: Stress granule dysfunction may impair clearance of toxic protein aggregates.
Alpha-Synuclein Toxicity: TIA1L may interact with alpha-synuclein aggregates, contributing to stress granule pathology in dopaminergic neurons.
ER Stress: TIA1L responds to ER stress, which is prominent in Parkinson's disease.
Polyglutamine Toxicity: TIA1L may be sequestered by mutant huntingtin aggregates, contributing to translational dysregulation[@brown2018].
Stress Granule Dynamics: Polyglutamine expansions alter stress granule formation and dynamics.
TIA1L participates in liquid-liquid phase separation (LLPS), a process by which proteins and RNAs form membraneless organelles within the cytoplasm. This process is driven by multivalent interactions between proteins and RNAs.
The Prion-Related Domain Drives Phase Separation
The prion-related domain (PRD) of TIA1L is critical for its phase separation behavior. This domain undergoes conformational changes that enable multimeric interactions, leading to the formation of liquid-like droplets that mature into stress granules.
Nucleation and Growth
Stress granule formation begins with nucleation, where TIA1L and related proteins form small assemblies. These assemblies grow through coalescence and the addition of more components until mature stress granules form.
Material Properties
Stress granules exhibit liquid-like properties initially but can mature into more solid-like assemblies over time. This maturation may be pathological in neurodegenerative diseases.
Translation Initiation Block
TIA1L represses translation at the initiation stage by interacting with eukaryotic initiation factor (eIF) 4G. This interaction prevents the formation of the translation initiation complex.
Ribosome Stalling
TIA1L-promoted stress granules contain stalled 48S preinitiation complexes. These complexes are stored rather than degraded, allowing for translation to resume after stress relief.
Selective Translation
TIA1L selectively represses specific mRNAs. mRNAs with complex 5' UTR structures or internal ribosome entry sites (IRES) may be preferentially retained in stress granules.
Stress granules contain multiple components:
RNA-Binding Proteins
Stress Granule Persistence
In ALS, stress granules persist beyond the initial stress, becoming pathogenic. TIA1L-positive stress granules accumulate in motor neurons, where they may seed the formation of larger aggregates.
TDP-43 Sequestration
TIA1L stress granules can sequester TDP-43 (TARDBP), a protein that forms characteristic inclusions in ALS. This sequestration may initiate TDP-43 pathology.
Translation Deficit
Persistent stress granule formation leads to chronic translation repression. This represses the synthesis of proteins needed for neuronal survival and function.
Therapeutic Implications
TDP-43 Pathology
FTD-TDP is characterized by TDP-43 inclusions. TIA1L is frequently found in these inclusions, suggesting that stress granule dysfunction is upstream of TDP-43 pathology.
Alternative Splicing Changes
TIA1L dysfunction may contribute to the alternative splicing changes observed in FTD, including changes in splicing factors and splicing patterns.
RNA Metabolism
FTD is associated with broad RNA metabolism deficits. TIA1L plays a central role in RNA metabolism, and its dysfunction contributes to these deficits.
Chronic Stress Response
Alzheimer's disease is associated with chronic oxidative stress, leading to persistent stress granule formation. TIA1L-positive stress granules are found in AD brain tissue.
Translational Deficits
TIA1L-mediated translation repression contributes to the synaptic protein deficits in AD. Restoring translation may improve synaptic function.
Protein Aggregate Interactions
TIA1L may be recruited to amyloid plaques and neurofibrillary tangles, contributing to stress granule formation.
Dopaminergic Neuron Vulnerability
Dopaminergic neurons are particularly vulnerable to stress. TIA1L stress granules form in response to cellular stresses relevant to PD.
Alpha-Synuclein Interaction
TIA1L may interact with alpha-synuclein, potentially seeding the formation of Lewy bodies.
Mitochondrial Stress
Parkinson's disease-associated mitochondrial stress triggers TIA1L stress granule formation.
The TIA family expanded during vertebrate evolution, with TIA1 and TIA1L arising from a common ancestor. Both proteins have conserved functions in stress response.
TIA1L is an RNA-binding protein critical for stress granule formation and mRNA translation control in neurons. Its dysfunction contributes to multiple neurodegenerative diseases, including ALS, FTD, Alzheimer's disease, and Parkinson's disease. The protein's role in stress granule formation makes it a potential therapeutic target. Understanding TIA1L functions and developing therapeutic approaches targeting its activity represent promising avenues for neurodegenerative disease treatment.